Assay	Technology	Target cancers for detection by assay																	Company/developer
		Lung	Colon/rectum	Breast	Pancreas	Liver	Esophagus	Stomach	Ovary	Prostate	Bladder	Kidney	Uterus	Head/neck	Lymphoma	Leukemia	Plasma cell	Brain
Adela	cfMeDIP sequencing; cfDNA fragmentomics																		Adela Bio
Tr(ACE)	Extracellular vesicle proteins; AI																		Biological Dynamics
Bluestar MCED	cfDNA 5-hydroxy methyl-cytosine sequencing; fragment omics																		Bluestar Genomics
OverC	ELSA sequencing																		Burning Rock
MIGPSai	cfDNA/cfRNA NGS; AI																		Caris Life Sciences
Delfi	cfDNA fragmentomics																		Delfi Diagnostics
cfMethyl-Seq	cfDNA methylcytosine NGS																		Early Diagnostics
MIRAM	Ultrahigh performance LC-MS glycosaminoglycans/Elypta’s SKY software																		Elypta
CancerSEEK	cfDNA NGS; protein markers																		Exact Sciences
FMBT	Multi-Omics/AI																		Freenome
Galleri	CpG-cfDNA NGS																		Grail
LungLB	CTC fluorescence in situ hybridization; imaging AI																		LungLife AI
Signatera	cfDNA NGS; protein markers																		Natera
Sentinel-10	CpG-cfDNA quantitative polymerase chain reaction																		Precision Epigenomics
OneTest	Circulating cancer antigens; AI																		20/20 GeneSystems
VPAC receptor TP4303	Near infrared optical microscopy																		Thomas Jefferson University/Intermountain Health
Acetylated polyamines	LC-MS/MS																		MD Anderson
Quantum Sensor/OncoProfiler	CTC surface-enhanced Raman scattering/machine learning																		Toronto Metropolitan University/St. Michael’s Hospital